Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ensysce Biosciences, Inc. - Common Stock
(NQ:
ENSC
)
0.5476
-0.0249 (-4.35%)
Delayed Quote
Updated: 1:55 PM EDT, Oct 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ensysce Biosciences, Inc. - Common Stock
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Why Is Ensyce Biosciences (ENSC) Stock Down 27% Today?
↗
July 01, 2022
Ensyce Biosciences (ENSC) stock is taking a beating on Friday after the clinical-stage biotech company announced $8 million in financing.
Via
InvestorPlace
Ensysce Biosciences Secures $8 Million Convertible Note Financing
July 01, 2022
~ Additional Funding from Investor Cohort Validates Company's Mission ~
From
Ensysce Biosciences, Inc.
Via
AccessWire
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
July 01, 2022
Via
Benzinga
Akebia Therapeutics And 20 Stocks Moving Premarket
↗
July 01, 2022
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on Thursday.
Via
Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
↗
July 01, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...
Via
Benzinga
Ensysce Biosciences Receives Notice of Award for 4th Year of Funding for Its Multi-Pill Abuse Resistance (MPAR(TM)) Platform
June 27, 2022
SAN DIEGO, CA / ACCESSWIRE / June 27, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC) (OTC:ENSCW), a clinical-stage biotech company applying transformative chemistry to...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Reminds Shareholders to Vote At Upcoming 2022 Virtual Annual Shareholder Meeting
June 21, 2022
- Shareholder Meeting to be Held on Thursday, June 23rd at 9:00 AM PT
From
Ensysce Biosciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
The Daily Biotech Pulse: INmune Bio's Planned Alzheimer's Trial On FDA Hold, Caladrius Stops Enrollment In Heart Disease Study, BiomX Restructures
↗
May 24, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Ensysce Biosciences Announces Initiation of First Human Abuse Potential Study
May 23, 2022
~ Nasal Opioid Abuse Being Explored for PF614 ~
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Provides Business Update and Reports First Quarter 2022 Financial Results
May 12, 2022
Corporate Update Call to be Held Tuesday, May 17, 2022 SAN DIEGO, CA / ACCESSWIRE / May 12, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Releases 2021 Annual Shareholder Letter
May 05, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Ensysce Biosciences, Inc.
Via
AccessWire
Topics
Death
Intellectual Property
Regulatory Compliance
Global Antibiotic Resistance Market to Hit US$16.5 Billion By 2030
April 21, 2022
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 21, 2022 – Resistance to antibiotics is a growing concern. About 750,000 people die each year worldwide from...
Via
FinancialNewsMedia
Dr. Lynn Kirkpatrick, Invited Speaker at SMi 22nd Annual Pain Therapeutics Conference in London UK
April 20, 2022
SAN DIEGO, CA / ACCESSWIRE / April 20, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to...
From
Ensysce Biosciences, Inc.
Via
AccessWire
Ensysce Biosciences Announces Appointment of Dr. Nily Osman as Chief Medical Officer
April 18, 2022
SAN DIEGO, CA / ACCESSWIRE / April 18, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to...
From
Ensysce Biosciences, Inc.
Via
AccessWire
51 Biggest Movers From Yesterday
↗
April 06, 2022
Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...
Via
Benzinga
Earnings Scheduled For March 31, 2022
↗
March 31, 2022
Companies Reporting Before The Bell • Trevena (NASDAQ:TRVN) is likely to report earnings for its fourth quarter.
Via
Benzinga
Ensysce Biosciences Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Timing of Corporate Update Call
March 24, 2022
SAN DIEGO, CA / ACCESSWIRE / March 24, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage biotech company applying transformative chemistry to...
From
Ensysce Biosciences, Inc.
Via
AccessWire
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
March 07, 2022
Gainers TherapeuticsMD (NASDAQ:TXMD) stock increased by 56.5% to $0.33 during Monday's pre-market session. The company's market cap stands at $139.7 million....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
March 07, 2022
Welcome back, trader! Let's get right into it with an overview of the biggest pre-market stock movers for Monday morning!
Via
InvestorPlace
42 Stocks Moving in Monday's Pre-Market Session
↗
March 07, 2022
Gainers Nine Energy Service, Inc. (NYSE: NINE) rose 96.7% to $3.54 in pre-market trading after climbing around 43% on Friday. Shares of low-priced energy stocks jumped as...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
February 18, 2022
Gainers HOOKIPA Pharma (NASDAQ:HOOK) stock moved upwards by 27.0% to $2.54 during Friday's regular session. The current volume of 40.0 million shares is 1123.6% of...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
February 11, 2022
Gainers Avenue Therapeutics (NASDAQ:ATXI...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
January 27, 2022
Gainers Avidity Biosciences (NASDAQ:RNA) s...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
January 21, 2022
Gainers Biophytis (NASDAQ:BPTS) shares rose 12.3% to $5.28 during Friday's regular session. The market value of their outstanding shares is at $68.0 million. Intra-...
Via
Benzinga
52 Biggest Movers From Yesterday
↗
January 20, 2022
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G...
Via
Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
↗
January 19, 2022
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion. Splash Beverage Group,...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 19, 2022
Gainers Zogenix (NASDAQ:ZGNX) stock rose 68.2% to $26.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.4 billion. Lucid...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
↗
January 19, 2022
Good morning, investor! We're diving right into trading today with a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
20 Stocks Moving in Wednesday's Pre-Market Session
↗
January 19, 2022
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares rose 56.1% to $24.41 in pre-market trading after UCB announced plans to acquire the company. Fresh Vine Wine, Inc. (NYSE: VINE) rose...
Via
Benzinga
23 Stocks Moving in Tuesday's Pre-Market Session
↗
January 18, 2022
Gainers ION Geophysical Corporation (NYSE: IO) shares rose 52.9% to $1.30 in pre-market trading after the company reported forbearance and amendment related to its revolving...
Via
Benzinga
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
